Order Article Reprints

Fleisher-Berkovich S, Ventura Y, Amoyal M, Dahan A, Feinshtein V, Alfahel L, Israelson A, Bernstein N, Gorelick J, Ben-Shabat S. Therapeutic Potential of Phytocannabinoid Cannabigerol for Multiple Sclerosis: Modulation of Microglial Activation In Vitro and In Vivo. Biomolecules. 2023; 13(2):376. https://doi.org/10.3390/biom13020376

Fleisher-Berkovich, Sigal, Yvonne Ventura, Maya Amoyal, Arik Dahan, Valeria Feinshtein, Leenor Alfahel, Adrian Israelson, Nirit Bernstein, Jonathan Gorelick, and Shimon Ben-Shabat. 2023. "Therapeutic Potential of Phytocannabinoid Cannabigerol for Multiple Sclerosis: Modulation of Microglial Activation In Vitro and In Vivo" Biomolecules 13, no. 2: 376. https://doi.org/10.3390/biom13020376

Fleisher-Berkovich, S., Ventura, Y., Amoyal, M., Dahan, A., Feinshtein, V., Alfahel, L., Israelson, A., Bernstein, N., Gorelick, J., & Ben-Shabat, S. (2023). Therapeutic Potential of Phytocannabinoid Cannabigerol for Multiple Sclerosis: Modulation of Microglial Activation In Vitro and In Vivo. Biomolecules, 13(2), 376. https://doi.org/10.3390/biom13020376